This study aims to evaluate the effect of cool baby oil on pruritus and sleep quality among uremic patient Research Hypothesis: * H01: There is no difference between hemodialysis patients with uremic pruritus who apply cool baby and those who apply placebo regarding sleep quality at 4 weeks follow-up * H02: There is no difference between hemodialysis patients with uremic pruritus who apply cool baby and those who apply placebo regarding itching severity at 4 weeks follow-up * H03: There is no difference between hemodialysis patients with uremic pruritus who apply cool baby and those who apply placebo regarding sleep quality at 12 weeks follow up * H04: There is no difference between hemodialysis patients with uremic pruritus who apply cool baby and those who apply placebo regarding itching severity at 12 weeks follow up * H1: Hemodialysis patients with uremic pruritus who apply cool baby oil will exhibit improved sleep quality than those who apply placebo at 4 weeks follow up * H2: Hemodialysis patients with uremic pruritus who apply cool baby oil will exhibit decreased itching severity than those who apply placebo at 4 weeks follow up * H3: Hemodialysis patients with uremic pruritus who apply cool baby oil will exhibit improved sleep quality than those who apply placebo at 12 weeks follow up * H4: Hemodialysis patients with uremic pruritus who apply cool baby oil will exhibit decreased itching severity than those who apply placebo at 12 weeks follow up
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
mean itching severity score at the baseline defined by Itching Severity Scale (ISS)
Timeframe: at the baseline (before assigning the participants to the study groups)
change of the mean Itching Severity Scale (ISS) at 4 weeks
Timeframe: after 4 weeks from the baseline
Change of the mean Itching Severity Scale (ISS) at 12 weeks
Timeframe: after 12 weeks from the baseline
Mean pruritus severity Score on Visual Analog Scale at the Baseline
Timeframe: at the baseline (before assigning the participants to the study groups)
Change from baseline mean of the pruritus severity score on the Visual Analog Scale at 4 weeks
Timeframe: after 4 weeks from the baseline
Change from baseline mean of the pruritus scores on the Visual Analog Scale at 12 weeks
Timeframe: after 12 weeks from the baseline
Mean score of the sleep quality on the Pittsburgh sleep quality index at the baseline
Timeframe: at the baseline (before assigning the participants to the study groups)
Change from baseline mean of the sleep quality on the Pittsburgh sleep quality index at 4 weeks
Timeframe: after 4 weeks from the baseline
Change from baseline mean of the sleep quality on the Pittsburgh sleep quality index at 12 weeks
Timeframe: after 12 weeks from the baseline